The total value of the global population health management market was USD 29.19 billion in 2021, and it will rise at a growth rate of above 14.9% shortly, reaching USD 101.89 billion by 2030, according to P&S Intelligence. This growth can be credited to the rapid revolution in the medicinal sector from a paper-based structure to the digital one, thus growing the demand for healthcare IT facilities. 

In 2021, the software category had a larger industry share. This can be credited to the rising acceptance of software solutions by workers and payers for the decrease in readmissions, development in operational effectiveness, and price efficiency. Furthermore, numerous advantages provided by this software, including improvement of patient engagement and help in information addition and analysis, are mushrooming the industry development in this category. 

In 2021, the on-premise category held the largest market share. This is mainly because of the numerous benefits related to it like lessening the danger of data breaching, the customization of medicinal solutions, and the capability to reuse present storage servers and hardware. Furthermore, the advanced security owing to the on-premise method of delivery is projected to enhance the market development in the coming few years. 

In 2021, Healthcare providers had the largest revenue share, of above 45%. This is mainly because of the performance of the Hospital Readmissions Reduction Program and Affordable Care Act in nations like the U.S., targeting lesser medicinal prices with the usage of new software in hospitals. 

This is growing the acceptance of population health management (PHM) results among health care workers. Correspondingly, governing rules, rising emphasis on lessening hospital readmission rates, and the high burden of medicinal bills are leading to substantial acceptance of such solutions by the workers. 

In 2021, North America held the largest population health management market share, of above 45%. Credited to the increasing federal command to decrease the growing medicinal prices and high execution of electronic well-being records and e-medical records in the continent. 

Furthermore, promulgating steps taken by government establishments to emphasize tailored drugs and their value-based repayments are other reasons for boosting regional industry development. Additionally, the rising usage of IT and cloud computing in infirmaries and the high occurrence of chronic illnesses are projected to boost the domain growth in the region. 

However, the APAC industry is projected to account for the highest CAGR, of approximately 15%, in the coming few years. This can be driven by the growing medicinal tourism in the  

APAC. In APAC, China, Japan, and India hold the major portion of the industry share, boosted by the high acceptance of new ICT rules in Japan, the increasing expenditure to revolutionize China’s medicinal infrastructure and the rapid development of India’s medicinal industry. 

SOURCE: P&S Intelligence